Literature DB >> 10629063

Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.

H X Liu1, S L Chew, L Cartegni, M Q Zhang, A R Krainer.   

Abstract

Exonic splicing enhancers (ESEs) are important cis elements required for exon inclusion. Using an in vitro functional selection and amplification procedure, we have identified a novel ESE motif recognized by the human SR protein SC35 under splicing conditions. The selected sequences are functional and specific: they promote splicing in nuclear extract or in S100 extract complemented by SC35 but not by SF2/ASF. They can also function in a different exonic context from the one used for the selection procedure. The selected sequences share one or two close matches to a short and highly degenerate octamer consensus, GRYYcSYR. A score matrix was generated from the selected sequences according to the nucleotide frequency at each position of their best match to the consensus motif. The SC35 score matrix, along with our previously reported SF2/ASF score matrix, was used to search the sequences of two well-characterized splicing substrates derived from the mouse immunoglobulin M (IgM) and human immunodeficiency virus tat genes. Multiple SC35 high-score motifs, but only two widely separated SF2/ASF motifs, were found in the IgM C4 exon, which can be spliced in S100 extract complemented by SC35. In contrast, multiple high-score motifs for both SF2/ASF and SC35 were found in a variant of the Tat T3 exon (lacking an SC35-specific silencer) whose splicing can be complemented by either SF2/ASF or SC35. The motif score matrix can help locate SC35-specific enhancers in natural exon sequences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10629063      PMCID: PMC85223          DOI: 10.1128/MCB.20.3.1063-1071.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Primary structure of the human splicing factor ASF reveals similarities with Drosophila regulators.

Authors:  H Ge; P Zuo; J L Manley
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  Consensus patterns in DNA.

Authors:  G D Stormo
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Distinct functions of SR proteins in alternative pre-mRNA splicing.

Authors:  A M Zahler; K M Neugebauer; W S Lane; M B Roth
Journal:  Science       Date:  1993-04-09       Impact factor: 47.728

4.  Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.

Authors:  S L Chew; H X Liu; A Mayeda; A R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

5.  A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA.

Authors:  M Tian; T Maniatis
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

6.  Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.

Authors:  A Mayeda; A R Krainer
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

7.  Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.

Authors:  A Mayeda; D M Helfman; A R Krainer
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

8.  A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding.

Authors:  A Lavigueur; H La Branche; A R Kornblihtt; B Chabot
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

9.  The role of exon sequences in splice site selection.

Authors:  A Watakabe; K Tanaka; Y Shimura
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

10.  Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.

Authors:  A R Krainer; A Mayeda; D Kozak; G Binns
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

View more
  92 in total

1.  SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.

Authors:  A Sureau; R Gattoni; Y Dooghe; J Stévenin; J Soret
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers.

Authors:  G Woerfel; A Bindereif
Journal:  Nucleic Acids Res       Date:  2001-08-01       Impact factor: 16.971

3.  Stop codons affect 5' splice site selection by surveillance of splicing.

Authors:  Binghui Li; Chaim Wachtel; Elana Miriami; Galit Yahalom; Gilgi Friedlander; Gil Sharon; Ruth Sperling; Joseph Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  Functional selection of splicing enhancers that stimulate trans-splicing in vitro.

Authors:  L A Boukis; J P Bruzik
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

5.  Functions of SR proteins in the U12-dependent AT-AC pre-mRNA splicing pathway.

Authors:  M L Hastings; A R Krainer
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

Review 6.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 7.  T' proteins influence JC virus biology.

Authors:  Richard J Frisque; Brigitte Bollag; Shiva K Tyagarajan; Lisa H Kilpatrick
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

8.  Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.

Authors:  Sònia Guil; Renata Gattoni; Montserrat Carrascal; Joaquín Abián; James Stévenin; Montse Bach-Elias
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.

Authors:  Ivan P Gorlov; Olga Y Gorlova; Marsha L Frazier; Christopher I Amos
Journal:  Am J Hum Genet       Date:  2003-10-01       Impact factor: 11.025

10.  Conserved sequence elements associated with exon skipping.

Authors:  Elana Miriami; Hanah Margalit; Ruth Sperling
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.